Bellevue Group AG

Q4 2023 13F Holdings Report, Options Holdings

Signature - Title
Christoph Eisenring / Michael Hutter - Head Legal & Compliance / CFO
Location
Kuesnacht, Switzerland
Options holdings as of
31 Dec 2023
Notional value $
$0
Number of holdings
0
Date filed
14 Feb 2024, 12:10
Description
All US holdings of this investor are reported in this report.
Previous filing
Q3 2023 - 14 Nov 2023
Next filing
Q1 2024 - 15 May 2024
Stock holdings
Showing options holdings, see here for stock holdings

Bellevue Group AG didn't report any options holdings as of Q4 2023. Check stock holdings.

Filing 2023 Q4 compared to 2023 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Christoph Eisenring / Michael Hutter Head Legal & Compliance / CFO Kuesnacht, Switzerland 12 Feb 2024

Other Included Managers (3):

Num Name Location File Number
1 Bb Biotech Ag Schaffhausen, Switzerland 028-06964
2 Bellevue Asset Management AG Zurich 028-16892
3 Bellevue Asset Management (UK) Ltd. London, United Kingdom 028-20408